Business

Philips braces for €250 mil hit due to product safety risk

Dutch firm says issue concerns sound-dampening foam in some sleep, respiratory care devices

Updated 5 years ago · Published on 26 Apr 2021 9:30PM

Philips braces for €250 mil hit due to product safety risk
The Amsterdam-based Philips started off as a lighting company more than 100 years ago, but has undergone major changes in recent years, focusing in particular on remote healthcare. – EPA pic, April 26, 2021

THE HAGUE – Dutch firm Philips today said it anticipates a hit of up to €250 million (RM1.2 billion) from a possible safety risk in some sleep and respiratory care products, even as first-quarter profits edged higher.

The company, which has diversified into healthcare and last month sold off its domestic appliance business, said net profit was €40 million in the three months to March 31, a 2.6% rise on a year earlier.

Philips had sales of €3.8 billion in Q1, up 3.6% from the same period last year.

“Regretfully, we have identified a quality issue in a component that is used in certain sleep and respiratory care products, and are initiating all precautionary actions to address this issue, for which we have taken a €250 million provision,” said CEO Frans van Houten in a statement.

Philips said there are “possible risks to users” from sound-dampening foam in some sleep and respiratory care devices, which could degrade under conditions including unapproved cleaning methods, plus high humidity and temperature. 

The firm said it is talking to regulators about the problem, which mainly affects first-generation DreamStation products, and “initiating appropriate actions to mitigate these possible risks”.

The Amsterdam-based company started off as a lighting firm more than 100 years ago, but has undergone major changes in recent years, focusing in particular on remote healthcare.

Philips announced last month that it is selling its home appliance business to Asian investment firm Hillhouse Capital for €3.7 billion, and sales from this are now listed under discontinued operations, according to today’s results statement.

The firm said despite continued “uncertainty” related to the Covid-19 pandemic, it has upgraded its sales forecast for 2021 on the back of increased demand for its healthcare products. – AFP, April 26, 2021

Related News

Malaysia / 1y

Gua Kepah prehistoric skeletal remains expected back in Penang by year end

Malaysia / 1y

Netherlands water management experts to help Sarawak with flooding and supply issues

Malaysia / 1y

Netherlands offers to help Sarawak in flood prevention

World / 3y

Dutch expel Russian diplomats, close trade mission

Our Planet / 3y

Dutch flood memories unleash new climate fears

World / 3y

Quran burning: Al-Azhar Uni calls for Swedish, Danish goods boycott

Spotlight

Malaysia

Women are pillars of national progress, community formation - PM Anwar

Malaysia

Muhyiddin's 'congratulatory' message to Hamzah a fake

Malaysia

Hamzah Zainudin launches new political party, Parti Wawasan Negara

Malaysia

Disturbing video of alleged employers assaulting their helper goes viral (video)

Malaysia

Illegal Rohingya settlement demolished after widespread public outcry

Malaysia

Three more political figures expected to be charged soon

Malaysia

Ten Johor “hotseat” constituencies set for fierce multi-cornered battles

You may be interested

Business

Singapore-based Galatek Technologies sets up production hub at Prai Industrial Estate

By Ian McIntyre